Amanita muscaria (fly agaric) is genuinely mind-altering, mainly from muscimol, which calms and sedates, and ibotenic acid, which is excitatory and can damage nerve cells. It is sold for calm, sleep, and mood, but no controlled human studies show benefit, while poisoning, delirium, and seizures are well documented and potency cannot be reliably controlled. (Full Review)

Protocol

Preparation

Thorough drying

Gentle low-heat decarboxylation converts ibotenic acid to muscimol; some traditions parboil and discard the water

Timing

Evening / before sleep

Daytime use discouraged due to drowsiness and impairment

Dosing

Single conservative dose

Long wait, no re-dosing within a session; stacking doses drives accidental overdose

Time to effect

Onset

30 min – 2 hours

Delayed, variable onset is a common cause of accidental overdose when re-dosing too soon

Duration

4 – 8 hours

Typical duration of effects

Half-life

A few hours

Short half-life of isolated muscimol; argues against frequent re-dosing

Benefits

Low: Subjective relaxation and reduced anxiety, sleep onset and sedation, topical and localized symptom relief

Speculative: Neuroregeneration and nerve repair, mood elevation and microdosing benefits

Contraindications

Pregnancy or breastfeeding

Epilepsy or any seizure disorder

Significant liver disease (Child-Pugh Class B or C)

Chronic kidney disease (eGFR below 60 mL/min/1.73m²)

Serious psychiatric illness

Operating vehicles or machinery

Key Interactions

CNS depressants (alcohol, benzodiazepines, barbiturates, opioids, Z-drugs)

GABAergic and anticonvulsant agents (sodium valproate, tiagabine, gabapentinoids)

Anticholinergic medications (diphenhydramine, oxybutynin, tricyclic antidepressants)

Other psychoactive substances (serotonergic psychedelics, stimulants, cannabis)

Sedative supplements (valerian, kava, high-dose magnesium, melatonin, GABA)

Risk & Side Effects

High: Acute neurotoxic poisoning, delirium and disorientation with injury risk

Medium: Seizures, severe sedation and respiratory depression

Low: Gastrointestinal distress, hepatic and renal stress

Speculative: Dependence and withdrawal, long-term neurotoxicity from ibotenic acid

Monitoring

Marker	Target	Why
ALT / AST	~10–26 U/L	Screen for liver stress and rule out hepatotoxic exposure
eGFR	>90 mL/min/1.73m²	Muscimol is renally excreted; reduced clearance prolongs effects
Serum creatinine	~0.6–1.0 mg/dL	Supports kidney-function assessment
Complete blood count (CBC)	Within standard reference ranges	General health screen before using a neuroactive substance

Cadence: At baseline, then periodically (e.g., every 6–12 months) if use is repeated

Qualitative Assessment

Cognitive clarity: any confusion, memory gaps, or impaired judgment during or after use
Sleep quality: whether sleep is genuinely restorative or merely sedated, including next-day grogginess
Mood stability: emergence of anxiety, dysphoria, or disinhibition
Adverse events: nausea, vomiting, twitching, or any seizure-like activity, which should prompt stopping and seeking care

Amanita muscaria for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment